Stephens Downgrades Bio-Techne (TECH) to Equal Weight
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- Wall St set to gain on tech rebound, Middle East in focus
- SpaceX prices historic IPO at $135/share in largest ever new listing
- Oil drops as Trump cancels planned strikes against Iran
- Intel rallies as BofA double-upgrades stock on increased CPU, foundry visibility
- Oppenheimer sees little strategic case for Tesla-SpaceX merger
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Axsome Therapeutics (AXSM) PT Raised to $380 at Jefferies
Janney Capital Upgrades Bio-Techne (TECH) to Neutral
October 28, 2015 12:53 PM EDTJanney Capital upgraded Bio-Techne (NASDAQ: TECH) from Buy to Neutral with a price target of $100.00 (from $118.00).
For an analyst ratings summary and ratings history on Bio-Techne click here. For more ratings news on Bio-Techne click here.
Shares of Bio-Techne closed at $95.94 yesterday.
... MoreBio-Techne (TECH) Misses Q1 EPS by 6c
October 28, 2015 7:06 AM EDTBio-Techne (NASDAQ: TECH) reported Q1 EPS of $0.79, $0.06 worse than the analyst estimate of $0.85. Revenue for the quarter came in at $12.4 million versus the consensus estimate of $116.4 million.
For earnings history and earnings-related data on Bio-Techne (TECH) click here.
... More